Logo image of QS

QUANTUMSCAPE CORP (QS) Stock Fundamental Analysis

USA - NYSE:QS - US74767V1098 - Common Stock

17.85 USD
+0.97 (+5.75%)
Last: 10/15/2025, 8:04:01 PM
18.2697 USD
+0.42 (+2.35%)
Pre-Market: 10/16/2025, 8:50:48 AM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to QS. QS was compared to 81 industry peers in the Automobile Components industry. QS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. QS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year QS has reported negative net income.
QS had a negative operating cash flow in the past year.
QS had negative earnings in each of the past 5 years.
In the past 5 years QS always reported negative operating cash flow.
QS Yearly Net Income VS EBIT VS OCF VS FCFQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

The Return On Assets of QS (-39.66%) is worse than 92.59% of its industry peers.
The Return On Equity of QS (-45.21%) is worse than 86.42% of its industry peers.
Industry RankSector Rank
ROA -39.66%
ROE -45.21%
ROIC N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
QS Yearly ROA, ROE, ROICQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

QS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QS Yearly Profit, Operating, Gross MarginsQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

QS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for QS is higher compared to a year ago.
QS Yearly Shares OutstandingQS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
QS Yearly Total Debt VS Total AssetsQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

QS has an Altman-Z score of 37.35. This indicates that QS is financially healthy and has little risk of bankruptcy at the moment.
QS has a better Altman-Z score (37.35) than 100.00% of its industry peers.
QS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
QS has a better Debt to Equity ratio (0.03) than 91.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 37.35
ROIC/WACCN/A
WACCN/A
QS Yearly LT Debt VS Equity VS FCFQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 16.40 indicates that QS has no problem at all paying its short term obligations.
QS has a Current ratio of 16.40. This is amongst the best in the industry. QS outperforms 98.77% of its industry peers.
QS has a Quick Ratio of 16.40. This indicates that QS is financially healthy and has no problem in meeting its short term obligations.
QS's Quick ratio of 16.40 is amongst the best of the industry. QS outperforms 98.77% of its industry peers.
Industry RankSector Rank
Current Ratio 16.4
Quick Ratio 16.4
QS Yearly Current Assets VS Current LiabilitesQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B

More info and screens

1

3. Growth

3.1 Past

QS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.47%, which is quite good.
EPS 1Y (TTM)9.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 20.42% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y12.13%
EPS Next 2Y8.66%
EPS Next 3Y9.56%
EPS Next 5Y20.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QS Yearly Revenue VS EstimatesQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
QS Yearly EPS VS EstimatesQS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QS Price Earnings VS Forward Price EarningsQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QS Per share dataQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.66%
EPS Next 3Y9.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUMSCAPE CORP

NYSE:QS (10/15/2025, 8:04:01 PM)

Premarket: 18.2697 +0.42 (+2.35%)

17.85

+0.97 (+5.75%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners33.13%
Inst Owner Change0.07%
Ins Owners2.5%
Ins Owner Change-0.12%
Market Cap10.10B
Analysts45.88
Price Target6.35 (-64.43%)
Short Float %12.45%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.85%
Min EPS beat(2)-1.22%
Max EPS beat(2)2.91%
EPS beat(4)2
Avg EPS beat(4)-0.25%
Min EPS beat(4)-6.33%
Max EPS beat(4)3.64%
EPS beat(8)4
Avg EPS beat(8)4.75%
EPS beat(12)4
Avg EPS beat(12)-3.85%
EPS beat(16)4
Avg EPS beat(16)-11.1%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)27.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.84%
EPS NY rev (1m)1.15%
EPS NY rev (3m)3.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9.86
P/tB 9.86
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0
BVpS1.81
TBVpS1.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.66%
ROE -45.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.4
Quick Ratio 16.4
Altman-Z 37.35
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)275.34%
Cap/Depr(5y)456.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y12.13%
EPS Next 2Y8.66%
EPS Next 3Y9.56%
EPS Next 5Y20.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.88%
EBIT Next 3Y14.41%
EBIT Next 5Y20.51%
FCF growth 1Y17.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.53%
OCF growth 3YN/A
OCF growth 5YN/A